Blueprint Medicines Corp Share | Buy US Stock from India on Kuvera

Q: Can I buy Blueprint Medicines Corp shares in India?

<div>Kuvera makes it super convenient to trade in US Stocks from India. You can buy / sell Blueprint Medicines Corp stocks after a simple registration process. </div>

Q: How to buy Blueprint Medicines Corp shares in India?

<div> To buy Blueprint Medicines Corp shares from India, just follow these simple steps: <div>Step 1: Login to the Kuvera app or website and go to US Stocks.</div> <div>Step 2: Link your existing Vested US investing account, or create a new one.</div> <div>Step 3: Complete all the KYC process and fund your US Stock trading account.</div> <div>Step 4: Place buy order for Blueprint Medicines Corp and you are done!</div> </div>

Q: What is the share price of Blueprint Medicines Corp?

<div>The share price of Blueprint Medicines Corp is USD 43.48 as on 24 Mar.</div>

Q: What is the Market Capitalization of Blueprint Medicines Corp?

<div>Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Blueprint Medicines Corp is USD 2.61B as on 24 Mar.</div>

Q: What is the PE ratio of Blueprint Medicines Corp?

<div> The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is overvalued in relation to the earnings (revenue) generated. PE ratio of Blueprint Medicines Corp is -4.69 as on 24 Mar. </div>

Q: Is Blueprint Medicines Corp a good stock to buy?

<div>Kuvera provides relevant fundamental details of Blueprint Medicines Corp to help you evaluate. We also recommend you do thorough research before making an investment decision.</div>

Q: In which sector / industry does Blueprint Medicines Corp operate?

<div> Blueprint Medicines Corp operates in Healthcare / Biotechnology

Healthcare Biotechnology

$43.48

-0.13

(24 Mar)

Loading Chart

Previous close

$43.48

Open

$43.48

52W high

$79.4

-32.53%

-14.38%

-4.69

EPS (TTM)

-9.35

Shares O/S

59.98M

Market cap

2.61B

Insights

BPMC price is below its 200 day moving average

In beta. Send feedback here.

Compare with other stock

About Blueprint Medicines Corp

Blueprint Medicines Corporation is a global precision therapy company that is inventing medicines for people with cancer and blood disorders. The Company delivers its approved medicines, including AYVAKIT/AYVAKYT (avapritinib) and GAVRETO (pralsetinib), to patients in the United States and Europe, and it is globally advancing multiple programs for systemic mastocytosis (SM), lung cancer, breast cancer and other genomically defined cancers, and cancer immunotherapy.

Its pipelines also include Elenestinib (BLU-263) (KIT), AYVAKIT (avapritinib) (KIT), Wild-type KIT research program, GAVRETO (pralsetinib) (RET), BLU-945 (EGFR), BLU-525 (EGFR), BLU-451 (EGFR exon 20 insertions), BLU-222 (CDK2), AYVAKIT (PDGFRA), GAVRETO (RET), BLU-222 (CDK2) and BLU-852 (MAP4K1). It is developing elenestinib (BLU-263), an investigational, orally available, potent and highly selective KIT inhibitor, for the treatment of indolent SM and other mast cell disorders. .

FAQs

Can I buy Blueprint Medicines Corp shares in India?

How to buy Blueprint Medicines Corp shares in India?

What is the share price of Blueprint Medicines Corp?

What is the Market Capitalization of Blueprint Medicines Corp?

What is the PE ratio of Blueprint Medicines Corp?

Is Blueprint Medicines Corp a good stock to buy?

In which sector / industry does Blueprint Medicines Corp operate?